Stock NewsYahooFinance Jazz Inks $7.2B Deal To Buy GW Pharmaceuticals Jazz Pharmaceuticals on Feb. 3 announced the acquisition of GW Pharmaceuticals for a total consideration of $7. Shrilekha Pethe, February 4, 2021
Stock NewsYahooFinance GWPH Explodes 21% As Epidiolex Roars Back Through The Pandemic Shares in GW Pharmaceuticals (GWPH) surged 21% in Tuesday’s trading, after the cannabis biopharma reported beats all round on the back of strong Epidiolex … Harriet Lefton, November 4, 2020
Stock NewsYahooFinance GW Pharma Scores New FDA Approval For CBD Drug Epidiolex Cannabis stock GW Pharma (GWPH) has announced that the US Food and Drug Administration (FDA) has approved Epidiolex oral solution for the treatment … Harriet Lefton, August 3, 2020
Stock NewsYahooFinance UK Relaxes Rules On GWPH Cannabis Drug Epidyolex; Analysts Bullish On Stock’s Prospects Cannabis stock GW Pharma (GWPH) has announced that the UK Home Office has lowered its classification of Epidyolex (cannabidiol). This change will take … Harriet Lefton, June 24, 2020
Stock NewsYahooFinance GW Pharma Pops 9% After-Hours As Epidiolex Smokes Expectations Cannabinoid prescription medicines stock GW Pharmaceuticals (GWPH) has reported particularly strong first quarter earnings results, with US sales of Epidiolex at $116.1M, up … Harriet Lefton, May 12, 2020
Analyst InsightsBiotech Stocks 3 Top Healthcare Stocks That Could Gain 35% — Or More Returns, that’s the name of the investing game. At the end of the day, investors are after the names that can help them … Maya Sasson, January 17, 2020
Analyst InsightsBiotech Stocks Morgan Stanley: 2 European Stocks to Overthrow the US Market Dominance The last decade, since the financial crisis of 2008 and the subsequent Great Recession, have seen a heavy dominance of US companies in … Scott Fields, October 23, 2019
AnalysisCannabis-Stock Buzz GW Pharmaceuticals (GWPH) Stock Is Dashing Towards a Brighter Future GW Pharmaceuticals (GWPH) announced on Monday that it had received approval to sell its epilepsy drug in the world’s largest market, as measured … Gary Bourgeault, September 26, 2019
AnalysisCannabis-Stock Buzz 6 Positive Catalysts to Drive GW Pharmaceuticals (GWPH) Stock Further The good news for GW Pharmaceuticals (GWPH) was it generated a profit in its latest reporting period. The bad news is it was … Gary Bourgeault, August 8, 2019
Uncategorized GW Pharmaceuticals (GWPH) Should Find a Place in Your Portfolio June has been one roller coaster ride for cannabis stocks. First, the FDA reported that CBD be treated like a drug causing cannabis … Ben Mahaney, Editor, June 13, 2019